Combination versus sequential paclitaxel plus gemcitabine as first-line chemotherapy for women with metastatic breast cancer: a prospective randomized phase II study.
第一作者:
Bin,Shao
第一单位:
Department of Medical Oncology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Haidian District, Beijing 100142, China.
作者:
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);癌, 导管, 乳腺(Carcinoma, Ductal, Breast);癌, 小叶状(Carcinoma, Lobular);脱氧胞苷(Deoxycytidine);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);淋巴转移(Lymphatic Metastasis);中年人(Middle Aged);紫杉酚(Paclitaxel);预后(Prognosis);前瞻性研究(Prospective Studies);存活率(Survival Rate)
PMID
30610781
发布时间
2022-12-07
- 浏览0
Journal of B.U.ON.
1583-1590页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文